6-(4-Benzylpiperazin-1-yl) benzodioxanes as selective ligands at cloned primate dopamine D 4 receptors
KJ Hodgetts, A Kieltyka, R Brodbeck, JN Tran…
Index: Hodgetts; Kieltyka; Brodbeck; Tran; Wasley; Thurkauf Bioorganic and Medicinal Chemistry, 2001 , vol. 9, # 12 p. 3207 - 3213
Full Text: HTML
Citation Number: 17
Abstract
A series of novel 6-(4-benzylpiperazin-1-yl) benzodioxanes were prepared and screened at selected dopamine receptor subtypes. 6-(4-[4-Chlorobenzyl] piperazin-1-yl) benzodioxane (2d) had high affinity and selectivity for the D4 dopamine receptor subtype and was identified as a D4 antagonist via its attenuation of dopamine-induced GTPγ35S binding at the D4 receptor.
Related Articles:
Discovery of small molecules that inhibit melanogenesis via regulation of tyrosinase expression
[Song, Jiho; Kim, Young Jin; Min, Kyung Hoon; Lee, Hyun-E; Kim, Su Yeon; Kim, Dong-Seok Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 22 p. 6943 - 6946,4]